What is the main business of Collran?

The main business activity of Collran focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 1, 2015.

Where is the headquarters located?

The headquarters is located at: ul. Wakacyjna 17, 35-317 Rzeszów.

What is the share capital?

The share capital of the company is PLN 20,000 (approx. $5,402).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2020 to December 31, 2020.

What was the revenue?

In 2020, the company generated total revenue of $102.

Yes, the company recorded a net profit of $0 in 2020.

Collransp. z o.o.

Q: Who is on the management board?

The management board consists of: Andrzej Kazimierz Argalski (Vice President of the Management Board), Joanna Magda Zacharska (President of the Management Board), and Marek Marian Szymański (Vice President of the Management Board).

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2015-07-01

Share capital

20,000.00 PLN

Registered address

ul. Wakacyjna 17, 35-317 Rzeszów, Poland

Financials

Revenue history

Filing timeliness

No financial statement for 2021 – the filing deadline has passed. 1 of 3 financial statements was filed late (for 2018, 821 days late), 1 not filed.

2021not filed
202013/10/2021
2019not filed
201813/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2020.

Results vs industry

Revenue

This companyUSD 101.80MedianUSD 917.74kAverageUSD 25.73m

Net profit

This companyUSD 0.00MedianUSD 14.44kAverageUSD 2.75m

Operating costs

This companyUSD 101.80MedianUSD 860.03kAverageUSD 21.34m

Assets

This companyUSD 30.36kMedianUSD 883.09kAverageUSD 31.39m

Industry

Authorized Representatives

Andrzej Kazimierz Argalski – Vice President of the Management Board

Joanna Magda Zacharska – President of the Management Board

Marek Marian Szymański – Vice President of the Management Board

Manner of representation

Joint action by the President of the Management Board with a member of the management board, or by the President of the Management Board together with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Collins Sp. z o.o. w Organizacji	10	$2,701.24	50%
Inveni sp. z o.o.	10	$2,701.24	50%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2017-01-02 to 2025-06-11.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication date	Event
Jan 23, 2026	Dissolution without liquidation opened
Mar 15, 2024	Dissolution without liquidation opened

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
ICN Polfa RzeszówS.A.	$85,044,250.03	icnpolfa.pl
LideoS.A.	$95,067.91	lideo.tech
Munar PharmaS.A.	$85,649.72	munar.pl
BIO Animalisp. z o.o.	$49,176.96	proanimali.com
Ampliconsp. z o.o.	$48,330.99	amplicon.pl
Xenira Pharmaceuticalssp. z o.o.	$26,670.82	xenirapharma.com
Sanford Biotechsp. z o.o.	$2,586.64	sanfordbiotech.com
Cefeasp. z o.o.	$294.66	cefea.pl
Auxilius PharmaS.A.	$0.83	auxiliuspharma.com
Bliss Pharmasp. z o.o.	$0.69	bliss-pharma.com

Change history

Date	Event
2016-11-24	Share capital increase (5,000.00 PLN → 20,000.00 PLN)
2016-11-24	Name change (Tars Consulting → Collran)
2016-11-24	PKD change (Removed: 1 code; Added: 10 codes)
2015-07-01	Entered in the register

FAQ

Last updated: 2026-04-13